company background image
LIVN logo

LivaNova NasdaqGS:LIVN Stock Report

Last Price

US$52.05

Market Cap

US$2.9b

7D

-1.0%

1Y

-0.2%

Updated

08 Oct, 2024

Data

Company Financials +

LIVN Stock Overview

A medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide.

LIVN fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance0/6
Financial Health5/6
Dividends0/6

LivaNova PLC Competitors

Price History & Performance

Summary of all time highs, changes and price drops for LivaNova
Historical stock prices
Current Share PriceUS$52.05
52 Week HighUS$64.48
52 Week LowUS$42.75
Beta1.01
11 Month Change10.60%
3 Month Change4.12%
1 Year Change-0.19%
33 Year Change-36.06%
5 Year Change-28.82%
Change since IPO333.75%

Recent News & Updates

Are Investors Undervaluing LivaNova PLC (NASDAQ:LIVN) By 31%?

Oct 02
Are Investors Undervaluing LivaNova PLC (NASDAQ:LIVN) By 31%?

LivaNova PLC's (NASDAQ:LIVN) Prospects Need A Boost To Lift Shares

Aug 21
LivaNova PLC's (NASDAQ:LIVN) Prospects Need A Boost To Lift Shares

Recent updates

Are Investors Undervaluing LivaNova PLC (NASDAQ:LIVN) By 31%?

Oct 02
Are Investors Undervaluing LivaNova PLC (NASDAQ:LIVN) By 31%?

LivaNova PLC's (NASDAQ:LIVN) Prospects Need A Boost To Lift Shares

Aug 21
LivaNova PLC's (NASDAQ:LIVN) Prospects Need A Boost To Lift Shares

LivaNova (NASDAQ:LIVN) Might Have The Makings Of A Multi-Bagger

Jul 30
LivaNova (NASDAQ:LIVN) Might Have The Makings Of A Multi-Bagger

At US$52.79, Is It Time To Put LivaNova PLC (NASDAQ:LIVN) On Your Watch List?

Jul 04
At US$52.79, Is It Time To Put LivaNova PLC (NASDAQ:LIVN) On Your Watch List?

Is LivaNova PLC (NASDAQ:LIVN) Trading At A 31% Discount?

Jun 13
Is LivaNova PLC (NASDAQ:LIVN) Trading At A 31% Discount?

LivaNova: Focus Is Paying Off

May 12

These Return Metrics Don't Make LivaNova (NASDAQ:LIVN) Look Too Strong

Apr 08
These Return Metrics Don't Make LivaNova (NASDAQ:LIVN) Look Too Strong

Is It Time To Consider Buying LivaNova PLC (NASDAQ:LIVN)?

Feb 05
Is It Time To Consider Buying LivaNova PLC (NASDAQ:LIVN)?

A Look At The Intrinsic Value Of LivaNova PLC (NASDAQ:LIVN)

Jan 15
A Look At The Intrinsic Value Of LivaNova PLC (NASDAQ:LIVN)

LivaNova PLC's (NASDAQ:LIVN) Business And Shares Still Trailing The Industry

Dec 25
LivaNova PLC's (NASDAQ:LIVN) Business And Shares Still Trailing The Industry

LivaNova (NASDAQ:LIVN) Could Be At Risk Of Shrinking As A Company

Nov 29
LivaNova (NASDAQ:LIVN) Could Be At Risk Of Shrinking As A Company

We Think LivaNova's (NASDAQ:LIVN) Profit Is Only A Baseline For What They Can Achieve

Nov 08
We Think LivaNova's (NASDAQ:LIVN) Profit Is Only A Baseline For What They Can Achieve

At US$47.94, Is LivaNova PLC (NASDAQ:LIVN) Worth Looking At Closely?

Oct 16
At US$47.94, Is LivaNova PLC (NASDAQ:LIVN) Worth Looking At Closely?

Are Investors Undervaluing LivaNova PLC (NASDAQ:LIVN) By 44%?

Sep 25
Are Investors Undervaluing LivaNova PLC (NASDAQ:LIVN) By 44%?

Capital Allocation Trends At LivaNova (NASDAQ:LIVN) Aren't Ideal

Jul 26
Capital Allocation Trends At LivaNova (NASDAQ:LIVN) Aren't Ideal

Should You Investigate LivaNova PLC (NASDAQ:LIVN) At US$51.43?

Jul 03
Should You Investigate LivaNova PLC (NASDAQ:LIVN) At US$51.43?

An Intrinsic Calculation For LivaNova PLC (NASDAQ:LIVN) Suggests It's 37% Undervalued

Jun 09
An Intrinsic Calculation For LivaNova PLC (NASDAQ:LIVN) Suggests It's 37% Undervalued

Investors Could Be Concerned With LivaNova's (NASDAQ:LIVN) Returns On Capital

Apr 13
Investors Could Be Concerned With LivaNova's (NASDAQ:LIVN) Returns On Capital

What Does LivaNova PLC's (NASDAQ:LIVN) Share Price Indicate?

Mar 13
What Does LivaNova PLC's (NASDAQ:LIVN) Share Price Indicate?

Estimating The Fair Value Of LivaNova PLC (NASDAQ:LIVN)

Feb 15
Estimating The Fair Value Of LivaNova PLC (NASDAQ:LIVN)

Returns At LivaNova (NASDAQ:LIVN) Are On The Way Up

Nov 25
Returns At LivaNova (NASDAQ:LIVN) Are On The Way Up

Is There Now An Opportunity In LivaNova PLC (NASDAQ:LIVN)?

Oct 29
Is There Now An Opportunity In LivaNova PLC (NASDAQ:LIVN)?

LivaNova Loses Profit Momentum On Higher R&D Expense

Oct 13

LivaNova PLC (NASDAQ:LIVN) Shares Could Be 30% Below Their Intrinsic Value Estimate

Oct 11
LivaNova PLC (NASDAQ:LIVN) Shares Could Be 30% Below Their Intrinsic Value Estimate

FDA labels recall of blood bypass pump systems by LivaNova as most serious

Sep 30

Returns On Capital At LivaNova (NASDAQ:LIVN) Have Hit The Brakes

Aug 09
Returns On Capital At LivaNova (NASDAQ:LIVN) Have Hit The Brakes

LivaNova PLC Non-GAAP EPS of $0.53 beats by $0.01, revenue of $254.2M beats by $4.65M, lowers FY earning guidance

Aug 03

Is There Now An Opportunity In LivaNova PLC (NASDAQ:LIVN)?

Jul 19
Is There Now An Opportunity In LivaNova PLC (NASDAQ:LIVN)?

A Look At The Fair Value Of LivaNova PLC (NASDAQ:LIVN)

Jun 27
A Look At The Fair Value Of LivaNova PLC (NASDAQ:LIVN)

LivaNova Matures Into Profitability, Still Waiting On DTD

May 10

Shareholder Returns

LIVNUS Medical EquipmentUS Market
7D-1.0%-3.0%-0.7%
1Y-0.2%19.8%30.3%

Return vs Industry: LIVN underperformed the US Medical Equipment industry which returned 19.8% over the past year.

Return vs Market: LIVN underperformed the US Market which returned 30.3% over the past year.

Price Volatility

Is LIVN's price volatile compared to industry and market?
LIVN volatility
LIVN Average Weekly Movement4.4%
Medical Equipment Industry Average Movement8.5%
Market Average Movement6.4%
10% most volatile stocks in US Market15.1%
10% least volatile stocks in US Market3.1%

Stable Share Price: LIVN has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: LIVN's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20152,900Vladimir Makatsariawww.livanova.com

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.

LivaNova PLC Fundamentals Summary

How do LivaNova's earnings and revenue compare to its market cap?
LIVN fundamental statistics
Market capUS$2.86b
Earnings (TTM)-US$16.59m
Revenue (TTM)US$1.21b

2.3x

P/S Ratio

-170.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LIVN income statement (TTM)
RevenueUS$1.21b
Cost of RevenueUS$387.71m
Gross ProfitUS$822.03m
Other ExpensesUS$838.61m
Earnings-US$16.59m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Oct 30, 2024

Earnings per share (EPS)-0.31
Gross Margin67.95%
Net Profit Margin-1.37%
Debt/Equity Ratio50.3%

How did LIVN perform over the long term?

See historical performance and comparison